More than half of patients with moderate atopic dermatitis experience a deterioration in quality of life similar to that of severe cases

A study in Spain reveals that moderate atopic dermatitis can influence both patients’ lives and the severe forms of the disease.

fotonoticia 20261117134140 1920

fotonoticia 20261117134140 1920

Add DEMÓCRATA to Google

Ask FREN

Published

3 minutes

Most read

Elecciones 29N · Encuestas

La media de las encuestas

Media a 16 de noviembre de 2026 · 17 institutos

  • PP31,5 %
  • PSOE27,2 %
  • Vox18,9 %
  • Frente Amplio6,4 %
  • ERC2,5 %
01020304050ene 2024jul 2024ene 2025jul 2025ene 2026jul 2026

Media del último estudio de cada instituto en 30 días y su evolución semanal desde el 23J. Partidos con al menos un 2 %.

Todas las encuestas

Elecciones generales del 29 de noviembre · Demócrata

The president of the Association of People Affected by Atopic Dermatitis (AADA) and patient, África Luca de Tena, together with the medical director of the pharmaceutical company Incyte Iberia, doctor Jacob González, have released the data in Spain from the European survey 'TOPIQAL'. The work reveals that more than 50 percent of those who suffer from moderate atopic dermatitis experience an impact on their day-to-day life comparable to that of the severe forms of the disease, to the point that 52.9 percent admit that their self-esteem and confidence are clearly harmed.

Luca de Tena recalled that "Atopic skin hides a reality that goes beyond physical burden," and pointed out that many patients with moderate involvement end up integrating the condition "into their routine and tend to keep going," a "normalization" that, as she has warned, "can be interpreted from outside as that being an irrelevant pathology or that you have total control over it, when in reality you live with a sustained burden, especially emotional and psychological, which is not always expressed or recognized".

The study, promoted by the AADA and Incyte on the occasion of National Atopic Dermatitis Day, which is commemorated on November 27, concludes that classifying atopic dermatitis as moderate does not always reflect the true impact it has on the lives of those who suffer from it. In many cases, the functional, emotional, and social impact is much higher than what their clinical category suggests.

Along these lines, doctor González has stressed that "There are still many things we do not know about moderate atopic dermatitis" and has insisted that the company's "commitment" is "to make a difference in the lives of people who, as in this case, because they have a condition classified as moderate does not mean it is less important, since it has a considerable emotional impact on them and on their environment." He also added: "That is why, and together with patients, we work to make available to them both innovative treatments as well as solutions to their needs not covered also from a sociosanitary perspective".

For his part, the head of the Dermatology Service at the La Paz University Hospital in Madrid, Dr. Pedro Herranz, has stressed that "between moderate and severe atopic dermatitis there is a very subtle line." In his view, "There are patients who suffer a great deal from the disease, with intense lesions, a lot of itching or involvement of visible areas, but they are classified as moderate when in reality they need hospital care."

Stigmatization and altered sleep in moderate atopic dermatitis

As Herranz has emphasized, "the atopic dermatitis that we call moderate has, in many cases, little that is moderate," since the levels of stigmatization that these patients report are practically the same as those who have severe disease, with scores of 19.25 versus 19. The survey, carried out in Spain among 1,047 adults (42.2 percent with moderate atopic dermatitis), shows that 63.8 percent try to hide the affected areas of skin, 48.6 percent avoid going out in family photographs, half have had to change their daily routines and 45 percent say that their personal life is restricted.

In addition, 67 percent acknowledge that their night-time rest is not restful; 69.2 percent have difficulties falling asleep; and 63.8 percent suffer from marked daytime fatigue. In the words of Luca de Tena, "Itching, visible lesions or concern about the condition of the skin can shape many everyday decisions," while Herranz insists that "we have to evaluate not only the skin, but also people's lives," warning that "it is a mistake to consider a patient as moderate who spends the night scratching and then has difficulties working."

The dermatologist has also highlighted the importance of "facilitating early access to safe and effective treatments that make it possible to individualize care." He recalled that "There are no two patients with atopic dermatitis who are the same and there are particularly sensitive areas, such as the face and neck, whose involvement can have a very significant impact on their lives."

From the AADA they stress that those affected "need comprehensive and individualized treatment because, although it may seem simple or a minor illness, it is a very heterogeneous disease in terms of symptoms, lesions, locations, or impacts on quality of life." Its representative has reiterated that the ultimate goal "is not only to improve the skin, but to normalize their life, which involves an appropriate medical assessment".